Synthetic mycoplasma-derived lipopeptide MALP-2 induces maturation and function of dendritic cells

Immunobiology

Volumn 207, Issue 3, 2003, Pages 223-233

  Weigt, Henning ^a   Mühlradt, Peter F ^b   Emmendörffer, Andreas ^c   Krug, Norbert ^a   Braun, Armin ^a  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^b Wound Healing Research Group   (Germany)

^c MODEX Therapeutics GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; MACROPHAGE ACTIVATING LIPOPEPTIDE 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DATA ANALYSIS; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MONOCYTE; MYCOPLASMA; POLARIZATION; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

EID: 0038189845     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00234     Document Type: Article

References (36)

1. Austyn JM. 1996. New insights into the mobilization and phagocytic activity of dendritic cells. J. Exp. Med. 183: 1287-1292.
2. Barton GM and Medzhitov R. 2002. Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14: 380-383.
3. Beutler B, Du X and Poltorak A. 2001. Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies. J. Endotoxin Res. 7: 277-280.
4. Calcutt MJ, Kim MF, Karpas AB, Muhlradt PF and Wise KS. 1999. Differential post-translational processing confers intraspecies variation of a major surface lipoprotein and a macrophage-activating lipopeptide of Mycoplasma fermentans. Infect. Immun. 67: 760-771.
5. Cao H, Verge V, Baron C, Martinache C, Leon A, Scholl S, Gorin NC, Salamero J, Assari S, Bernard J and Lopez M. 2000. In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy. J. Hematother. Stem Cell Res. 9: 183-194.
6. de Jong EC, Vieira PL, Kalinski P, Schuitemaker JH, Tanaka Y, Wierenga EA, Yazdanbakhsh M and Kapsenberg ML. 2002. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J. Immunol. 168: 1704-1709.
7. Dieu-Nosjean MC, Vicari A, Lebecque S and Caux C. 1999. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J. Leukoc. Biol. 66: 252-262.
8. Duperrier K, Eljaafari A, Dezutter-Dambuyant C, Bardin C, Jacquet C, Yoneda K, Schmitt D, Gebuhrer L and Rigal D. 2000. Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements. J. Immunol. Methods 238: 119-131.
9. Galanos C, Gumenscheimer M, Muhlradt P, Jirillo E and Freudenberg M. 2000. MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly? J. Endotoxin. Res. 6: 471-476.
10. Granucci F, Ferrero E, Foti M, Aggujaro D, Vettoretto K and Ricciardi-Castagnoli P. 1999. Early events in dendritic cell maturation induced by LPS. Microbes. Infect. 1: 1079-1084.
11. Guermonprez P, Valladeau J, Zitvogel L, Thery C and Amigorena S. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20: 621-667.
12. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K and Akira S. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
13. Hogan MM and Vogel SN. 2000. Measurement of Tumor Necrosis Factor α and β. Current Protocols in Immunology. Supplement 37: 6.10.1-6.10.5.
14. Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, Young RA, Lander ES and Hacohen N. 2001. The plasticity of dendritic cell responses to pathogens and their components. Science 294: 870-875.
15. Jarrossay D, Napoletani G, Colonna M, Sallusto F and Lanzavecchia A. 2001. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31: 3388-3393.
16. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F and Liu YJ. 2001. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863-869.
17. Kaisho T and Akira S. 2002. Toll-like receptors as adjuvant receptors. Biochim. Biophys Acta 1589: 1-13.
18. Kalinski P, Schuitemaker JH, Hilkens CM, Wierenga EA and Kapsenberg ML. 1999. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J. Immunol. 162: 3231-3236.
19. Kondo T, Cortese I, Markovic-Plese S, Wandinger KP, Carter C, Brown M, Leitman S and Martin R. 2001. Dendritic cells signal T cells in the absence of exogenous antigen. Nat. Immunol. 2: 932-938.
20. Koski GK, Lyakh LA and Rice NR. 2001. Rapid lipopolysaccharide-induced differentiation of CD14(+) monocytes into CD83(+) dendritic cells is modulated under serum-free conditions by exogenously added IFN-gamma and endogenously produced IL-10. Eur. J Immunol. 31: 3773-3781.
21. Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, Giese T, Engelmann H, Endres S, Krieg AM and Hartmann G. 2001. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31: 3026-3037.
22. Lanzavecchia A and Sallusto F. 2001. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 13: 291-298.
23. Liu YJ, Kanzler H, Soumelis V and Gilliet M. 2001. Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2: 585-589.
24. Mackensen A, Drager R, Schlesier M, Mertelsmann R and Lindemann A. 2000. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol. Immunother. 49: 152-156.
25. Medzhitov R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1: 135-145.
26. Medzhitov R, Preston-Hurlburt P and Janeway CA Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
27. Mizel SB and Snipes JA. 2002. Gram-negative flagellin-induced self-tolerance is associated with a block in IRAK release from TLR5. J. Biol. Chem. 277: 22414-22420.
28. Morr M, Takeuchi O, Akira S, Simon M and Muhlradt P. 2002. Differential recognition of structural details of bacterial lipopetides by toll-like receptors. Eur. J. Immunol. 32: 3337-3347.
29. Muzio M, Bosisio D, Polentarutti N, D'amico G, Stoppacciaro A, Mancinelli R, van't Veer C, Penton-Rol G, Ruco LP, Allavena P and Mantovani A. 2000. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164: 5998-6004.
30. Nishiguchi M, Matsumoto M, Takao T, Hoshino M, Shimonishi Y, Tsuji S, Begum NA, Takeuchi O, Akira S, Toyoshima K and Seya T. 2001. Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions. J. Immunol. 166: 2610-2616.
31. Ratta M, Rondelli D, Fortuna A, Curti A, Fogli M, Fagnoni F, Martinelli G, Terragna C, Tura S and Lemoli RM. 1998. Generation and functional characterization of human dendritic cells derived from CD34 cells mobilized into peripheral blood: comparison with bone marrow CD34+cells. Br. J Haematol. 101: 756-765.
32. Ruschmeyer D, Thude H and Muhlradt PF. 1993. MDHM, a macrophage-activating product of Mycoplasma fermentans, stimulates murine macrophages to synthesize nitric oxide and become tumoricidal. FEMS Immunol. Med. Microbiol. 7: 223-229.
33. Scheinecker C, Machold KP, Majdic O, Hocker P, Knapp W and Smolen JS. 1998. Initiation of the autologous mixed lymphocyte reaction requires the expression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells. J. Immunol. 161: 3966-3973.
34. Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, Morr M, Muhlradt PF, and Akira S. 2000. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164: 554-557.
35. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K and Akira S. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13: 933-940.
36. Thery C and Amigorena S. 2001. The cell biology of antigen presentation in dendritic cells. Curr. Opin. Immunol. 13: 45-51.